대원제약(주) · KOSPI: 003220 · Pharmaceuticals and medicinal chemicals
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩527.0B | ₩598.2B | ₩605.4B |
| Operating income | ₩32.2B | ₩28.2B | ₩3.5B |
| Net income | ₩23.5B | ₩9.0B | −₩4.0B |
| Total assets | ₩508.0B | ₩583.4B | ₩613.7B |
| Total liabilities | ₩243.7B | ₩298.8B | ₩339.1B |
| Total equity | ₩264.3B | ₩284.6B | ₩274.6B |
| Share capital | ₩11.1B | ₩11.2B | ₩11.2B |
Consolidated statements · FY2025 operating margin 0.6% · liabilities to equity 123% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 65 (current) | 예지회계법인 | Unqualified |
| Term 64 (prior) | 삼정회계법인 | Unqualified |
| Term 63 (two years prior) | 삼정회계법인 | Unqualified |
No change history reported in the latest annual report.
| Date | Filing | Original |
|---|---|---|
| 2026-09-15 | Investor relations event (notice) | DART |
| 2026-08-28 | Fair trade compliance program status (notice) | DART |
| 2026-08-07 | Half-year report (2026.06) | DART |
| 2026-06-12 | Investor relations event (notice) | DART |
| 2026-06-10 | Officer / major shareholder ownership report | DART |
| 2026-06-01 | Corporate governance report | DART |
| 2026-05-15 | Quarterly report (2026.03) | DART |
| 2026-03-26 | Annual general meeting results | DART |
| 2026-03-26 | Independent director appointment / dismissal / resignation | DART |
| 2026-03-18 | Annual report (2025.12) | DART |
| 2026-03-18 | Audit report submitted | DART |
| 2026-03-13 | Officer / major shareholder ownership report | DART |
| 2026-03-11 | Amended: Notice of shareholders meeting | DART |
| 2026-03-11 | Amended: Resolution to convene shareholders meeting | DART |
| 2026-02-27 | Fair trade compliance program status (notice) | DART |
| 2026-02-25 | Notice of shareholders meeting | DART |
| 2026-02-24 | Adjustment of conversion / exercise / exchange price (notice) | DART |
| 2026-02-20 | Resolution to convene shareholders meeting | DART |
| 2026-02-20 | Cash / in-kind dividend decision | DART |
| 2026-02-03 | Revenue or profit structure changed materially | DART |
Showing the 20 most recent of 29 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.